“…Many synthetic cathinones, including mephedrone, MDPV, α-PVP, function as reinforcers in this paradigm and are readily self-administered via the intravenous route, as reviewed elsewhere (Watterson and Olive, 2014, Aarde and Taffe, 2017, Watterson and Olive, 2017). Yet most, if not all, of these prior studies in rodents were conducted under conditions of limited daily access (e.g, 1–6 hr/day), and it is clear from a myriad of case reports that human synthetic cathinones users often engage in binge-like patterns of intake spanning several consecutive days or even weeks (Winstock et al, 2011, Ross et al, 2012, Forrester, 2013, Gunderson et al, 2013, Miotto et al, 2013, Wright et al, 2013, Hall et al, 2014, Palamar et al, 2015, Barrio et al, 2016). It is therefore of great importance to implement rodent models of long term repeated binge-like self-administration patterns that are frequently observed in human synthetic cathinone users.…”